참고문헌
- World Cancer Research Fund; American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, D.C.: WCRF/AICR; 2007.
- Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22(4): 191-197. https://doi.org/10.1055/s-0029-1242458
- Boyle P, Langman JS. ABC of colorectal cancer: epidemiology. BMJ 2000; 321(7264): 805-808. https://doi.org/10.1136/bmj.321.7264.805
- Young GP, Le Leu RK. Preventing cancer: dietary lifestyle or clinical intervention? Asia Pac J Clin Nutr 2002; 11 Suppl 3: S618-S631. https://doi.org/10.1046/j.0964-7058.2002.00337.x
- Na SY, Myung SJ. Obesity and colorectal cancer. Korean J Gastroenterol 2012; 59(1): 16-26. https://doi.org/10.4166/kjg.2012.59.1.16
- Padidar S, Farquharson AJ, Williams LM, Kearney R, Arthur JR, Drew JE. High-fat diet alters gene expression in the liver and colon: links to increased development of aberrant crypt foci. Dig Dis Sci 2012; 57(7): 1866-1874. https://doi.org/10.1007/s10620-012-2092-9
- Sung MK, Yeon JY, Park SY, Park JH, Choi MS. Obesityinduced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci 2011; 1229: 61-68.
- Schlesinger S, Lieb W, Koch M, Fedirko V, Dahm CC, Pischon T, Nothlings U, Boeing H, Aleksandrova K. Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Obes Rev 2015; 16(7): 607-619. https://doi.org/10.1111/obr.12286
-
Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, Greenberg AS, Mason JB. Diet-induced obesity elevates colonic TNF-
${\alpha}$ in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem 2012; 23(10): 1207-1213. https://doi.org/10.1016/j.jnutbio.2011.07.002 - Jochem C, Leitzmann M. Obesity and colorectal cancer. Recent Results Cancer Res 2016; 208: 17-41.
- Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 2009; 9(1): 31-59. https://doi.org/10.2174/138955709787001712
- Ashokkumar P, Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother 2008; 62(9): 590-597. https://doi.org/10.1016/j.biopha.2008.06.031
-
Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, Mizuno M. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-
${\kappa}B$ inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors 2013; 39(5): 522-533. https://doi.org/10.1002/biof.1091 - Salib JY, Michael HN, Eskande EF. Anti-diabetic properties of flavonoid compounds isolated from Hyphaene thebaica epicarp on alloxan induced diabetic rats. Pharmacognosy Res 2013; 5(1): 22-29. https://doi.org/10.4103/0974-8490.105644
- Pandurangan AK, Esa NM. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review. Asian Pac J Cancer Prev 2014; 15(14): 5501-5508. https://doi.org/10.7314/APJCP.2014.15.14.5501
-
Zhang X, Zhang QX, Wang X, Zhang L, Qu W, Bao B, Liu CA, Liu J. Dietary luteolin activates browning and thermogenesis in mice through an
$AMPK/PGC1{\alpha}$ pathway-mediated mechanism. Int J Obes (Lond) 2016; 40(12): 1841-1849. https://doi.org/10.1038/ijo.2016.108 - Kwon EY, Jung UJ, Park T, Yun JW, Choi MS. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes 2015; 64(5): 1658-1669. https://doi.org/10.2337/db14-0631
-
Zhang L, Han YJ, Zhang X, Wang X, Bao B, Qu W, Liu J. Luteolin reduces obesity-associated insulin resistance in mice by activating
$AMPK{\alpha}$ 1 signalling in adipose tissue macrophages. Diabetologia 2016; 59(10): 2219-2228. -
Ding L, Jin D, Chen X. Luteolin enhances insulin sensitivity via activation of
$PPAR{\gamma}$ transcriptional activity in adipocytes. J Nutr Biochem 2010; 21(10): 941-947. https://doi.org/10.1016/j.jnutbio.2009.07.009 -
Nepali S, Son JS, Poudel B, Lee JH, Lee YM, Kim DK. Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-
${\kappa}B$ /mitogen-activated protein kinases pathway. Pharmacogn Mag 2015; 11(43): 627-635. https://doi.org/10.4103/0973-1296.160470 - Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69(2): 238-249.
- Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000; 21(4): 757-768. https://doi.org/10.1093/carcin/21.4.757
- Tanaka T, Kohno H, Suzuki R, Hata K, Sugie S, Niho N, Sakano K, Takahashi M, Wakabayashi K. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer 2006; 118(1): 25-34. https://doi.org/10.1002/ijc.21282
- Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115(1): 182-205. https://doi.org/10.1016/S0016-5085(98)70381-6
- Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15(1): 79-94. https://doi.org/10.1128/CMR.15.1.79-94.2002
- Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, Buchan I. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010; 126(3): 692-702. https://doi.org/10.1002/ijc.24803
- Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007; 16(12): 2533- 2547. https://doi.org/10.1158/1055-9965.EPI-07-0708
- Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997; 89(13): 948-955. https://doi.org/10.1093/jnci/89.13.948
- Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86(3): 556-565. https://doi.org/10.1093/ajcn/86.3.556
- Baltgalvis KA, Berger FG, Peña MM, Davis JM, Carson JA. The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice. Cancer Prev Res (Phila) 2009; 2(7): 641-649. https://doi.org/10.1158/1940-6207.CAPR-09-0017
- Tang FY, Pai MH, Chiang EP. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem 2012; 23(10): 1302-1313. https://doi.org/10.1016/j.jnutbio.2011.07.011
- Reddy BS. Types and amount of dietary fat and colon cancer risk: Prevention by omega-3 fatty acid-rich diets. Environ Health Prev Med 2002; 7(3): 95-102. https://doi.org/10.1265/ehpm.2002.95
- Dai W, Liu T, Wang Q, Rao CV, Reddy BS. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Int J Oncol 2002; 20(1): 121-126.
- van Beelen VA, Spenkelink B, Mooibroek H, Sijtsma L, Bosch D, Rietjens IM, Alink GM. An n-3 PUFA-rich microalgal oil diet protects to a similar extent as a fish oil-rich diet against AOM-induced colonic aberrant crypt foci in F344 rats. Food Chem Toxicol 2009; 47(2): 316-320. https://doi.org/10.1016/j.fct.2008.11.014
- Kang KA, Piao MJ, Ryu YS, Hyun YJ, Park JE, Shilnikova K, Zhen AX, Kang HK, Koh YS, Jeong YJ, Hyun JW. Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells. Int J Oncol 2017; 51(4): 1169-1178. https://doi.org/10.3892/ijo.2017.4091
-
Pandurangan AK, Dharmalingam P, Sadagopan SK, Ramar M, Munusamy A, Ganapasam S. Luteolin induces growth arrest in colon cancer cells through involvement of
$Wnt/{\beta}$ -catenin/$GSK-3{\beta}$ signaling. J Environ Pathol Toxicol Oncol 2013; 32(2): 131-139. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2013007522 - Lim DY, Jeong Y, Tyner AL, Park JH. Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastrointest Liver Physiol 2007; 292(1): G66-G75. https://doi.org/10.1152/ajpgi.00248.2006
- Ramos AA, Pereira-Wilson C, Collins AR. Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells. Mutat Res 2010; 692(1-2): 6-11. https://doi.org/10.1016/j.mrfmmm.2010.07.004
- Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, Ganapasam S. Luteolin, a bioflavonoid, attenuates azoxymethaneinduced effects on mitochondrial enzymes in BALB/c mice. Asian Pac J Cancer Prev 2014; 14(11): 6669-6672. https://doi.org/10.7314/APJCP.2013.14.11.6669
- Pandurangan AK, Dharmalingam P, Sadagopan SK, Ganapasam S. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Hum Exp Toxicol 2014; 33(11): 1176-1185. https://doi.org/10.1177/0960327114522502
- Rankin JW, Turpyn AD. Low carbohydrate, high fat diet increases C-reactive protein during weight loss. J Am Coll Nutr 2007; 26(2): 163-169. https://doi.org/10.1080/07315724.2007.10719598
- Kim IW, Myung SJ, Do MY, Ryu YM, Kim MJ, Do EJ, Park S, Yoon SM, Ye BD, Byeon JS, Yang SK, Kim JH. Westernstyle diets induce macrophage infiltration and contribute to colitis-associated carcinogenesis. J Gastroenterol Hepatol 2010; 25(11): 1785-1794. https://doi.org/10.1111/j.1440-1746.2010.06332.x
- Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodiuminduced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 2007; 28(9): 1450-1459. https://doi.org/10.1111/j.1745-7254.2007.00695.x
- Park YH, Kim N, Shim YK, Choi YJ, Nam RH, Choi YJ, Ham MH, Suh JH, Lee SM, Lee CM, Yoon H, Lee HS, Lee DH. Adequate dextran sodium sulfate-induced colitis model in mice and effective outcome measurement method. J Cancer Prev 2015; 20(4): 260-267.
- Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol 2014; 18(4): 279-288. https://doi.org/10.4196/kjpp.2014.18.4.279
- Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethaneinduced rat colon carcinogenesis. Carcinogenesis 2000; 21(7): 1319-1327. https://doi.org/10.1093/carcin/21.7.1319
- Ahn B, Ohshima H. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res 2001; 61(23): 8357-8360.
- Yagihashi N, Kasajima H, Sugai S, Matsumoto K, Ebina Y, Morita T, Murakami T, Yagihashi S. Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch 2000; 436(2): 109-114. https://doi.org/10.1007/PL00008208
- Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002; 53: 35-57.